[Clinical evaluation of 2 new formulations of desmopressin (DDAVP), nasal spray and tablets, in the therapy of diabetes insipidus].

A clinical evaluation was carried out in patients suffering from diabetes insipidus using two new formulations of desmopressin (DDAVP), the nose spray and tablets. 10 patients were included in the study. In them the drug's activity and the bioequivalence between the two pharmaceutical forms examined were compared.